Literature DB >> 21029774

Iron loading-induced aggregation and reduction of iron incorporation in heteropolymeric ferritin containing a mutant light chain that causes neurodegeneration.

Barry B Muhoberac1, Martin A Baraibar, Ruben Vidal.   

Abstract

Hereditary ferritinopathy (HF) is a neurodegenerative disease characterized by intracellular ferritin inclusion bodies (IBs) and iron accumulation throughout the central nervous system. Ferritin IBs are composed of mutant ferritin light chain as well as wild-type light (Wt-FTL) and heavy chain (FTH1) polypeptides. In vitro studies have shown that the mutant light chain polypeptide p.Phe167SerfsX26 (Mt-FTL) forms soluble ferritin 24-mer homopolymers having a specific structural disruption that explains its functional problems of reduced ability to incorporate iron and aggregation during iron loading. However, because ferritins are usually 24-mer heteropolymers and all three polypeptides are found in IBs, we investigated the properties of Mt-FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymeric ferritins. We show here the facile assembly of Mt-FTL and FTH1 subunits into soluble ferritin heteropolymers, but their ability to incorporate iron was significantly reduced relative to Wt-FTL/FTH1 heteropolymers. In addition, Mt-FTL/FTH1 heteropolymers formed aggregates during iron loading, contrasting Wt-FTL/FTH1 heteropolymers and similar to what was seen for Mt-FTL homopolymers. The resulting precipitate contained both Mt-FTL and FTH1 polypeptides as do ferritin IBs in patients with HF. The presence of Mt-FTL subunits in Mt-FTL/Wt-FTL heteropolymers also caused iron loading-induced aggregation relative to Wt-FTL homopolymers, with the precipitate containing Mt- and Wt-FTL polypeptides again paralleling HF. Our data demonstrate that co-assembly with wild-type subunits does not circumvent the functional problems caused by mutant subunits. Furthermore, the functional problems characterized here in heteropolymers that contain mutant subunits parallel those problems previously reported in homopolymers composed exclusively of mutant subunits, which strongly suggests that the structural disruption characterized previously in Mt-FTL homopolymers occurs in a similar manner and to a significant extent in both Mt-FTL/FTH1 and Mt-FTL/Wt-FTL heteropolymers.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029774      PMCID: PMC3040265          DOI: 10.1016/j.bbadis.2010.10.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease.

Authors:  A R Curtis; C Fey; C M Morris; L A Bindoff; P G Ince; P F Chinnery; A Coulthard; M J Jackson; A P Jackson; D P McHale; D Hay; W A Barker; A F Markham; D Bates; A Curtis; J Burn
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

2.  Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy.

Authors:  Xiaoling Deng; Ruben Vidal; Ella W Englander
Journal:  Neurosci Lett       Date:  2010-05-15       Impact factor: 3.046

3.  Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights.

Authors:  Michelangelo Mancuso; Guido Davidzon; Roger M Kurlan; Rabi Tawil; Eduardo Bonilla; Salvatore Di Mauro; James M Powers
Journal:  J Neuropathol Exp Neurol       Date:  2005-04       Impact factor: 3.685

4.  Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene.

Authors:  Ana G Barbeito; Holly J Garringer; Martin A Baraibar; Xiaoying Gao; Miguel Arredondo; Marco T Núñez; Mark A Smith; Bernardino Ghetti; Ruben Vidal
Journal:  J Neurochem       Date:  2009-03-30       Impact factor: 5.372

5.  Unraveling of the E-helices and disruption of 4-fold pores are associated with iron mishandling in a mutant ferritin causing neurodegeneration.

Authors:  Martin A Baraibar; Barry B Muhoberac; Holly J Garringer; Thomas D Hurley; Ruben Vidal
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

6.  Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene.

Authors:  R Vidal; B Ghetti; M Takao; C Brefel-Courbon; E Uro-Coste; B S Glazier; V Siani; M D Benson; P Calvas; L Miravalle; O Rascol; M B Delisle
Journal:  J Neuropathol Exp Neurol       Date:  2004-04       Impact factor: 3.685

7.  Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice.

Authors:  Ruben Vidal; Leticia Miravalle; Xiaoying Gao; Ana G Barbeito; Martin A Baraibar; Shahryar K Hekmatyar; Mario Widel; Navin Bansal; Marie B Delisle; Bernardino Ghetti
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

8.  A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations.

Authors:  Akatsuki Kubota; Ayumi Hida; Yaeko Ichikawa; Yoshio Momose; Jun Goto; Yukifusa Igeta; Hideji Hashida; Kunihiro Yoshida; Syu-Ichi Ikeda; Ichiro Kanazawa; Shoji Tsuji
Journal:  Mov Disord       Date:  2009-02-15       Impact factor: 10.338

9.  Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.

Authors:  David Devos; P Jissendi Tchofo; Isabelle Vuillaume; Alain Destée; Stephanie Batey; John Burn; Patrick F Chinnery
Journal:  Brain       Date:  2008-10-14       Impact factor: 13.501

10.  Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration.

Authors:  Martin A Baraibar; Ana G Barbeito; Barry B Muhoberac; Ruben Vidal
Journal:  J Biol Chem       Date:  2008-08-28       Impact factor: 5.157

View more
  15 in total

Review 1.  Mammalian iron metabolism and its control by iron regulatory proteins.

Authors:  Cole P Anderson; Macy Shen; Richard S Eisenstein; Elizabeth A Leibold
Journal:  Biochim Biophys Acta       Date:  2012-05-17

2.  A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage.

Authors:  Martin A Baraibar; Ana G Barbeito; Barry B Muhoberac; Ruben Vidal
Journal:  Free Radic Biol Med       Date:  2012-02-17       Impact factor: 7.376

3.  Mutant L-chain ferritins that cause neuroferritinopathy alter ferritin functionality and iron permeability.

Authors:  Justin R McNally; Matthew R Mehlenbacher; Sara Luscieti; Gideon L Smith; Aliaksandra A Reutovich; Poli Maura; Paolo Arosio; Fadi Bou-Abdallah
Journal:  Metallomics       Date:  2019-10-16       Impact factor: 4.526

4.  Investigation of the Biological Impact of Charge Distribution on a NTR1-Targeted Peptide.

Authors:  Yinnong Jia; Wenting Zhang; Wei Fan; Susan Brusnahan; Jered Garrison
Journal:  Bioconjug Chem       Date:  2016-10-21       Impact factor: 4.774

5.  Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.

Authors:  Ana G Barbeito; Thierry Levade; Marie B Delisle; Bernardino Ghetti; Ruben Vidal
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

Review 6.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

7.  Abnormal iron homeostasis and neurodegeneration.

Authors:  Barry B Muhoberac; Ruben Vidal
Journal:  Front Aging Neurosci       Date:  2013-07-30       Impact factor: 5.750

Review 8.  Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Authors:  Sonia Levi; Dario Finazzi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

Review 9.  Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism.

Authors:  Sonia Levi; Ermanna Rovida
Journal:  Neurobiol Dis       Date:  2015-03-12       Impact factor: 5.996

10.  Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy.

Authors:  Holly J Garringer; Jose M Irimia; Wei Li; Charles B Goodwin; Briana Richine; Anthony Acton; Rebecca J Chan; Munro Peacock; Barry B Muhoberac; Bernardino Ghetti; Ruben Vidal
Journal:  PLoS One       Date:  2016-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.